A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2011
03/10/2011	WO2011028416A2 Oral medication for the treatment of hemorrhoids and method of use
03/10/2011	WO2011028334A2 Synthesis and isolation of dendrimer systems
03/10/2011	WO2011028328A1 Stabilized wax compositions and uses thereof
03/10/2011	WO2011028314A1 Plant-based omega chewable supplement
03/10/2011	WO2011028288A1 Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
03/10/2011	WO2011028255A2 Desferrithiocin polyether analogues and uses thereof
03/10/2011	WO2011028234A1 Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid
03/10/2011	WO2011028135A1 Kinase inhibitors, prodrug forms thereof and their use in therapy
03/10/2011	WO2011028112A1 Imidazole-4-carboxylic acid for use in treating a disease related to extracellular reactive oxygen species
03/10/2011	WO2011028110A1 Composition for topical application, uses thereof, applicator device and kit of parts
03/10/2011	WO2011028044A2 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
03/10/2011	WO2011028043A2 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
03/10/2011	WO2011027988A2 Novel polymorphic form of prasugrel-hydrogen sulfate
03/10/2011	WO2011027893A1 Method for prediction of therapeutic effect on chronic hepatitis c
03/10/2011	WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof
03/10/2011	WO2011027849A1 Heterocyclic compound
03/10/2011	WO2011027829A1 Composition containing rna derived from lactic acid bacterium as active ingredient
03/10/2011	WO2011027805A1 Therapeutic agent for mood disorders
03/10/2011	WO2011027786A1 Transdermally absorbable preparation
03/10/2011	WO2011027778A1 Composition for topical administration to eyes for use in treatment of ocular hypertension and glaucoma
03/10/2011	WO2011027706A1 Porous structure
03/10/2011	WO2011027551A1 Hydrogen sulfide-producing enzyme inhibitor
03/10/2011	WO2011027373A1 Composition containing ultra-micronized palmitoyl - ethanolamide
03/10/2011	WO2011027363A2 Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
03/10/2011	WO2011027348A1 Pharmaceutical composition comprising a3 adenosine receptor agonist (ib-meca/cf-101) for treatment of psoriasis
03/10/2011	WO2011027344A2 Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders
03/10/2011	WO2011027333A1 Granulated anthelmintic preparations and delivery systems
03/10/2011	WO2011027330A1 Inhibition of histone acetyltransferases by ctk7a and methods thereof
03/10/2011	WO2011027324A1 Polymorphic forms of atazanavir sulfate
03/10/2011	WO2011027322A1 Extended release dosage form containing olopatadine for oral administration
03/10/2011	WO2011027289A1 Chromone derivatives, a process for their preparation and their therapeutic applications
03/10/2011	WO2011027249A2 Benzimidazole derivatives
03/10/2011	WO2011027247A1 An antifungal cream comprising terbinafine hydrochloride
03/10/2011	WO2011027246A1 A cream comprising miconazole nitrate and a biopolymer for the treatment of diaper rash
03/10/2011	WO2011027156A1 Benzodiazepine derivatives for treating hepatitis c infection
03/10/2011	WO2011027128A1 Use of non-digestible oligosaccharides
03/10/2011	WO2011027119A1 Combination medicament
03/10/2011	WO2011027106A1 Therapeutic aryl-am i do-aryl compounds and their use
03/10/2011	WO2011027081A2 Novel derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof
03/10/2011	WO2011027046A1 Use of secnidazole in combination with an active antibiotic against aerobic bacteria for treating diverticulitis
03/10/2011	WO2011027021A1 A method for the treatment of hypertension
03/10/2011	WO2011027009A1 Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same
03/10/2011	WO2011026959A1 Novel ethane diamine hepcidin antagonists
03/10/2011	WO2011026920A1 Bis-benzimidazole derivatives
03/10/2011	WO2011026917A1 Heteroaryl compounds as kinase inhibitors
03/10/2011	WO2011026912A2 Mir-10a inhibitors and inhibitors of hoxb1 and/or hoxb3 repressors in the blocking of metastatic behaviour of pancreatic cancer
03/10/2011	WO2011026911A1 Bipyridines useful for the treatment of proliferative diseases
03/10/2011	WO2011026904A1 Pyrazinylpyridines useful for the treatment of proliferative diseases
03/10/2011	WO2011026891A1 Substituted pyridine derivatives and their medical use
03/10/2011	WO2011026835A1 Novel pyrimidine and triazine hepcidine antagonists
03/10/2011	WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use
03/10/2011	WO2011026579A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
03/10/2011	WO2011026571A1 Novel combination of a corticosteroid with a phosphonic acid derivative
03/10/2011	WO2011026536A1 Novel therapeutic concepts for treating fibromyalgia
03/10/2011	WO2011026529A1 Novel antibacterial hydroxyphenyl compound
03/10/2011	WO2011026401A1 Anti-tumor natural medicines coupled with nitric oxide donors and pharmaceutical uses thereof
03/10/2011	WO2011026349A1 Dipeptide boronic acid containing β-amino acid and carboxylic acids, its ester compounds, preparation method and use thereof
03/10/2011	WO2011026312A1 Novel matrix slow release tablet containing metoprolol succinate
03/10/2011	WO2011026267A1 Antiphlogistic, antioncotic and analgesic chinese herbal composition,preparative method and usage thereof
03/10/2011	WO2011026259A1 Pharmaceutical compositon for anti-thrombotic diseases, its preparation method and use
03/10/2011	WO2011026241A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy
03/10/2011	WO2011026240A1 Oxopiperazine derivatives for the treatment of pain and epilepsy
03/10/2011	WO2011026234A1 Clarithromycin extended-release tablet
03/10/2011	WO2011026219A1 Combination therapy for cancer comprising a platinum -based antineoplastic agent and a biocompatible electron donor
03/10/2011	WO2011026216A1 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease
03/10/2011	WO2011026206A1 Isolated nucleic acid sequence, expression vector, synergistic immunogenic composition comprising an expression vector that codes for the e7 protein of human papilloma virus (hpv) fused with the gd-protein of human herpes virus type-1 (hsv-1), and an expression vector that codes for a cytokyne, and uses thereof
03/10/2011	WO2011018672A8 Methods and substances for stimulating muscle regeneration
03/10/2011	WO2011009020A3 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
03/10/2011	WO2011008666A3 3-phenoxymethylpyrrolidine compounds
03/10/2011	WO2011004402A3 Improved process for the preparation of ambrisentan and novel intermediates thereof
03/10/2011	WO2011002857A3 3-cyanoquinoline tablet formulations and uses thereof
03/10/2011	WO2010149383A3 Ceramide dimers and the use thereof as pharmaceutical products or cosmetic preparation
03/10/2011	WO2010147302A3 Novel intermediates of voriconazole and preparation method of voriconazole using the same
03/10/2011	WO2010146601A4 Rapid dissolvable oral film for delivering herbal extract/s with or without other pharmaceutically active agents
03/10/2011	WO2010141586A3 Therapeutic ophthalmic emulsions
03/10/2011	WO2010139411A3 17β-ALKYL-17α-OXY-ESTRATRIENES
03/10/2011	WO2010135527A9 Elastin for soft tissue augmentation
03/10/2011	WO2010130462A8 Phosphate-free pharmaceutical composition for the treatment of glaucoma
03/10/2011	WO2010129321A3 Topical compositions comprising an alkoxylated diphenylacrylate compound and an aryl carboxylic ester
03/10/2011	WO2010129145A3 Methods and compositions for treating dry eye
03/10/2011	WO2010127205A3 Fixed dose drug combination formulations
03/10/2011	WO2010121877A3 Process for the preparation of olopatadine
03/10/2011	WO2010121226A3 Anticancer agents
03/10/2011	WO2010118367A3 Antiviral pyrimidines
03/10/2011	WO2010117756A3 Substituted benzimidazole pharmaceutical formulations
03/10/2011	WO2010117170A3 Pharmaceutical composition for treating or preventing burn injuries
03/10/2011	WO2010115078A3 Method of treating cognitive impairment
03/10/2011	WO2010115053A9 Methods of using canonical wnts as enhancers for bone formation by human bone-marrow derived mesenchymal stem cells
03/10/2011	WO2010111718A3 Antiviral compounds and methods of use thereof
03/10/2011	WO2010108657A3 C5a binding nucleic acids and the use thereof
03/10/2011	WO2010107742A3 Methods and compositions of treating a flaviviridae family viral infection
03/10/2011	WO2010107739A3 Methods and compositions of treating a flaviviridae family viral infection
03/10/2011	WO2010093727A8 Quinazolinones as prolyl hydroxylase inhibitors
03/10/2011	WO2010068281A3 Contact lens drug delivery device
03/10/2011	WO2010037127A8 Chromenone analogs as sirtuin modulators
03/10/2011	WO2010010101A8 Isosorbide nitrates having vasodilating activity
03/10/2011	WO2009130735A8 Fatty acid derivatives for oral administration endowed with high palatability
03/10/2011	US20110060309 Implantable Device for Controlled Drug Delivery
03/10/2011	US20110060060 Pterostilbene as a New Agonist for the Peroxisome Proliferator-Activated Receptor Alpha Isoform
03/10/2011	US20110060059 Inhibition of the Survival of Bladder Cancer by Cyclohexenone Compounds from Antrodia Camphorata

1 ... 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 ... 7860